The question bank is the fastest way to start, but PMHNP Helper also includes board-review planning, student resources, and plain-English guidance for psychiatric nurse practitioner students who are still learning the exam landscape.
A 32-year-old male veteran with PTSD has been receiving prolonged exposure therapy for 10 sessions and was started on sertraline 150 mg daily eight weeks ago. His PTSD Checklist for DSM-5 (PCL-5) score has decreased from 58 at baseline to 41 at today's visit. He reports decreased frequency of intrusive memories and nightmares, improved ability to engage in previously avoided activities, and less hypervigilance in public settings. However, he continues to experience emotional numbing, difficulty feeling close to family members, and persistent sleep-onset insomnia. His wife reports he has been more engaged at home but still has angry outbursts approximately twice weekly. The PMHNP is evaluating the treatment response. Which interpretation of the PCL-5 score and clinical data is most accurate?
Explanation
The PCL-5 is a validated tool for monitoring PTSD treatment response, with a reliable change index of approximately 10 points and clinically meaningful change thresholds of 10 to 20 points. Comprehensive evaluation includes examining both total score changes and cluster-level patterns to inform targeted treatment adjustments, while integrating functional outcomes and collateral information alongside standardized scores.
Key Takeaway
PCL-5 interpretation should include comparison against reliable change and clinically meaningful change thresholds, cluster-level analysis to guide targeted treatment adjustments, and integration with functional outcome data.